BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24954548)

  • 1. The evaluation of statins as potential inhibitors of the LEDGF/p75-HIV-1 integrase interaction.
    Harrison AT; Kriel FH; Papathanasopoulos MA; Mosebi S; Abrahams S; Hewer R
    Chem Biol Drug Des; 2015 Mar; 85(3):290-5. PubMed ID: 24954548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of the interactions between HIV-1 IN and the cofactor LEDGF/p75.
    De Luca L; Ferro S; Morreale F; De Grazia S; Chimirri A
    ChemMedChem; 2011 Jul; 6(7):1184-91. PubMed ID: 21506277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LEDGF/p75 integrase interaction, a novel target for anti-HIV therapy.
    Christ F; Debyser Z
    Virology; 2013 Jan; 435(1):102-9. PubMed ID: 23217620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/p75.
    Bartholomeeusen K; De Rijck J; Busschots K; Desender L; Gijsbers R; Emiliani S; Benarous R; Debyser Z; Christ F
    J Mol Biol; 2007 Sep; 372(2):407-21. PubMed ID: 17669426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the LEDGF/p75 binding site in HIV-1 integrase.
    Busschots K; Voet A; De Maeyer M; Rain JC; Emiliani S; Benarous R; Desender L; Debyser Z; Christ F
    J Mol Biol; 2007 Feb; 365(5):1480-92. PubMed ID: 17137594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for antiviral inhibitors of the HIV integrase-LEDGF/p75 interaction using the AlphaScreen luminescent proximity assay.
    Hou Y; McGuinness DE; Prongay AJ; Feld B; Ingravallo P; Ogert RA; Lunn CA; Howe JA
    J Biomol Screen; 2008 Jun; 13(5):406-14. PubMed ID: 18480474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacophore-based discovery of small-molecule inhibitors of protein-protein interactions between HIV-1 integrase and cellular cofactor LEDGF/p75.
    De Luca L; Barreca ML; Ferro S; Christ F; Iraci N; Gitto R; Monforte AM; Debyser Z; Chimirri A
    ChemMedChem; 2009 Aug; 4(8):1311-6. PubMed ID: 19565598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein.
    Hayouka Z; Hurevich M; Levin A; Benyamini H; Iosub A; Maes M; Shalev DE; Loyter A; Gilon C; Friedler A
    Bioorg Med Chem; 2010 Dec; 18(23):8388-95. PubMed ID: 20974536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virtual-screening targeting Human Immunodeficiency Virus type 1 integrase-lens epithelium-derived growth factor/p75 interaction for drug development.
    Gu WG; Liu BN; Yuan JF
    J Drug Target; 2015 Feb; 23(2):134-9. PubMed ID: 25230778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New scaffolds of natural origin as Integrase-LEDGF/p75 interaction inhibitors: virtual screening and activity assays.
    De Luca L; Morreale F; Christ F; Debyser Z; Ferro S; Gitto R
    Eur J Med Chem; 2013 Oct; 68():405-11. PubMed ID: 23994868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.
    Al-Mawsawi LQ; Christ F; Dayam R; Debyser Z; Neamati N
    FEBS Lett; 2008 Apr; 582(10):1425-30. PubMed ID: 18331842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage.
    Le Rouzic E; Bonnard D; Chasset S; Bruneau JM; Chevreuil F; Le Strat F; Nguyen J; Beauvoir R; Amadori C; Brias J; Vomscheid S; Eiler S; Lévy N; Delelis O; Deprez E; Saïb A; Zamborlini A; Emiliani S; Ruff M; Ledoussal B; Moreau F; Benarous R
    Retrovirology; 2013 Nov; 10():144. PubMed ID: 24261564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel inhibitors of LEDGF/p75-IN protein-protein interactions.
    Sanchez TW; Debnath B; Christ F; Otake H; Debyser Z; Neamati N
    Bioorg Med Chem; 2013 Feb; 21(4):957-63. PubMed ID: 23306052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitors.
    Feng L; Sharma A; Slaughter A; Jena N; Koh Y; Shkriabai N; Larue RC; Patel PA; Mitsuya H; Kessl JJ; Engelman A; Fuchs JR; Kvaratskhelia M
    J Biol Chem; 2013 May; 288(22):15813-20. PubMed ID: 23615903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,4-Bis(5-(naphthalen-1-yl)thiophen-2-yl)naphthalene, a small molecule, functions as a novel anti-HIV-1 inhibitor targeting the interaction between integrase and cellular Lens epithelium-derived growth factor.
    Gu WG; Ip DT; Liu SJ; Chan JH; Wang Y; Zhang X; Zheng YT; Wan DC
    Chem Biol Interact; 2014 Apr; 213():21-7. PubMed ID: 24480521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1,2,3,4-Tetrahydroisoquinolines as inhibitors of HIV-1 integrase and human LEDGF/p75 interaction.
    George A; Gopi Krishna Reddy A; Satyanarayana G; Raghavendra NK
    Chem Biol Drug Des; 2018 Jun; 91(6):1133-1140. PubMed ID: 29405651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking the interaction between HIV-1 integrase and human LEDGF/p75: mutational studies, virtual screening and molecular dynamics simulations.
    Reddy KK; Singh P; Singh SK
    Mol Biosyst; 2014 Mar; 10(3):526-36. PubMed ID: 24389668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small-molecule inhibitors of the LEDGF/p75 binding site of integrase block HIV replication and modulate integrase multimerization.
    Christ F; Shaw S; Demeulemeester J; Desimmie BA; Marchand A; Butler S; Smets W; Chaltin P; Westby M; Debyser Z; Pickford C
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4365-74. PubMed ID: 22664975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of Structure-active Relationship for Inhibitors of HIV-1 Integrase LEDGF/p75 Interaction by Machine Learning Methods.
    Li Y; Wu Y; Yan A
    Mol Inform; 2017 Jul; 36(7):. PubMed ID: 28244220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.
    Feng L; Dharmarajan V; Serrao E; Hoyte A; Larue RC; Slaughter A; Sharma A; Plumb MR; Kessl JJ; Fuchs JR; Bushman FD; Engelman AN; Griffin PR; Kvaratskhelia M
    ACS Chem Biol; 2016 May; 11(5):1313-21. PubMed ID: 26910179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.